DE60215548D1 - Anti-allergische pharmazeutische Zusammensetzung - Google Patents

Anti-allergische pharmazeutische Zusammensetzung

Info

Publication number
DE60215548D1
DE60215548D1 DE60215548T DE60215548T DE60215548D1 DE 60215548 D1 DE60215548 D1 DE 60215548D1 DE 60215548 T DE60215548 T DE 60215548T DE 60215548 T DE60215548 T DE 60215548T DE 60215548 D1 DE60215548 D1 DE 60215548D1
Authority
DE
Germany
Prior art keywords
synthesis
pharmaceutical composition
allergen
cells
histamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60215548T
Other languages
English (en)
Inventor
Emile Loria
Gaetan Terrasse
Yves Trehin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antialis
Original Assignee
Antialis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26212944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60215548(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0104370A external-priority patent/FR2822708A1/fr
Application filed by Antialis filed Critical Antialis
Application granted granted Critical
Publication of DE60215548D1 publication Critical patent/DE60215548D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DE60215548T 2001-03-30 2002-03-28 Anti-allergische pharmazeutische Zusammensetzung Expired - Lifetime DE60215548D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0104370A FR2822708A1 (fr) 2001-03-30 2001-03-30 Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
FR0105929A FR2822709B1 (fr) 2001-03-30 2001-05-03 Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
US09/867,159 US7048928B2 (en) 2001-03-30 2001-05-29 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound

Publications (1)

Publication Number Publication Date
DE60215548D1 true DE60215548D1 (de) 2006-11-30

Family

ID=26212944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60215548T Expired - Lifetime DE60215548D1 (de) 2001-03-30 2002-03-28 Anti-allergische pharmazeutische Zusammensetzung

Country Status (8)

Country Link
US (1) US7048928B2 (de)
EP (2) EP1414489A2 (de)
AT (1) ATE342732T1 (de)
AU (1) AU2002308044A1 (de)
BR (1) BR0208710A (de)
DE (1) DE60215548D1 (de)
FR (1) FR2822709B1 (de)
WO (1) WO2002078736A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6994870B2 (en) * 2002-09-18 2006-02-07 Jaw-Ji Tsai Local nasal immunotherapy with allergen strip for allergic rhinitis
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
CN100536845C (zh) * 2003-09-23 2009-09-09 中国医学科学院药物研究所 氯雷他定透皮贴片
US20100166804A1 (en) * 2007-05-23 2010-07-01 Dennis Penn Methods
EP2167084B1 (de) * 2007-06-12 2013-04-24 ALK-Abelló A/S Allergen-dosierform mit einem antihistamin
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
WO2009142772A2 (en) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
US20160251367A1 (en) * 2014-11-13 2016-09-01 Chrysalis Pharma Synthesis of tritoqualine salts
BR112017017894A2 (pt) 2015-02-20 2018-04-10 Univ Leland Stanford Junior composições de alérgenos misturados e métodos para usar as mesmas
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
FR3048883B1 (fr) * 2016-03-18 2020-10-02 Gaetan Terrasse Utilisation d'une molecule h4 agoniste pour le traitement de la fibrose pulmonaire idiopathique
US11382934B2 (en) 2017-07-18 2022-07-12 Before Brands, Inc. Methods for making mixed allergen compositions
KR20210130147A (ko) 2019-01-23 2021-10-29 비포어 브랜즈, 인크. 혼합 알레르겐 조성물의 제조 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302458A (en) * 1979-10-24 1981-11-24 Laborec Laboratoire De Recherches Biologiques Phthalidyl-isoquinoline derivatives
FI812469L (fi) * 1980-08-18 1982-02-19 Merck & Co Inc Synergistisk foerening av (r s)alfa-fluormetylhistidin och simetidin som saorbildning foerhindrande aemnen
US5863561A (en) * 1982-06-03 1999-01-26 Stolle Research & Development Corporation Immune suppressive product
AU624077B2 (en) * 1987-06-17 1992-06-04 Institute For Child Health Research Cloning of mite allergens
US5256680A (en) * 1988-11-29 1993-10-26 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
US5433948A (en) * 1990-02-13 1995-07-18 Thomas; Wayne R. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
JPH08509725A (ja) * 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
AU674584B2 (en) * 1993-06-02 1997-01-02 Tvw Telethon Institute For Child Health Research Cryptic peptides for use in inducing immunologic tolerance
US5968526A (en) * 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
IN188720B (de) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
US6455686B1 (en) * 1998-04-17 2002-09-24 Heska Corporation Dermatophagoides nucleic acid molecules, proteins and uses thereof
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
WO2000050455A2 (en) * 1999-02-25 2000-08-31 Tai June Yoo Antigen to systemic lupus erythematosis and diagnostic assay

Also Published As

Publication number Publication date
FR2822709B1 (fr) 2007-01-19
EP1473041A3 (de) 2004-11-24
FR2822709A1 (fr) 2002-10-04
AU2002308044A1 (en) 2002-10-15
WO2002078736A2 (fr) 2002-10-10
EP1473041B1 (de) 2006-10-18
US7048928B2 (en) 2006-05-23
US20030104013A1 (en) 2003-06-05
WO2002078736A3 (fr) 2004-02-19
EP1414489A2 (de) 2004-05-06
BR0208710A (pt) 2004-08-24
EP1473041A2 (de) 2004-11-03
ATE342732T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
DE60215548D1 (de) Anti-allergische pharmazeutische Zusammensetzung
CY2008009I1 (el) 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειικο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
ATE416771T1 (de) N-ä4-(4-amino-2-ethyl-1h-imidazoä4,5-cüchinolin 1-yl)butylümethanesulfonamide, diese enthaltende pharmazeutische zusammensetzung und deren verwendung
DE69927803D1 (de) Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen.
ATE495154T1 (de) Pharmazeutische zusammensetzungen, die ccr5- antagonisierende piperazinderivate enthalten
NO20020348L (no) Peptid acceptor ligeringsmetoder
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
NO20010062D0 (no) Bifenylsulfonamider som duale angiotensin-endotelin- reseptorantagonister
NO20052975D0 (no) Nye 2',5'-oligoadenylsyreanaloger.
WO1998058957A3 (en) Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
HK1052461A1 (en) Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid.
WO2005007675A3 (en) TRIAZOLE ϵ-AMINO ACIDS
EP1724283A3 (de) Agonisten des corticotropin-freisetzenden Faktor Rezeptors 2
ATE385517T1 (de) Interferon ähnliche moleküle, und deren verwendungen
AR030379A1 (es) Combinaciones
ZA200305877B (en) Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof.
WO2002059327A3 (en) Sulfatases and methods of use thereof
HUP0300727A3 (en) Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
BR0212523A2 (pt) Ácido nucléico, polipeptídeo purificado e seus usos
WO2001019973A3 (en) Nicotinic acetylcholine receptor: alpha10 subunit
WO2004031365A3 (en) Sulfatases and methods of use thereof
WO2004052916A3 (en) Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids
IL162880A0 (en) Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyk) dodecanoic acid
WO2003048106A3 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation

Legal Events

Date Code Title Description
8332 No legal effect for de